View of EVALUATION OF THE EFFECTIVENESS OF COMPLEX THERAPY USING A PROBIOTIC AND REBAMIPIDE ON THE DYNAMICS OF BIOLOGICAL MARKERS OF INTESTINAL DAMAGE AND DYSBIOTIC CHANGES IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE AFTER COVID-19

Return to Article Details EVALUATION OF THE EFFECTIVENESS OF COMPLEX THERAPY USING A PROBIOTIC AND REBAMIPIDE ON THE DYNAMICS OF BIOLOGICAL MARKERS OF INTESTINAL DAMAGE AND DYSBIOTIC CHANGES IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE AFTER COVID-19 Download Download PDF